These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24018266)

  • 1. Mild cognitive impairment and anti-Alzheimer disease medications: A cross sectional study of the French National Alzheimer Databank (BNA).
    Tifratene K; Sakarovitch C; Rouis A; Pradier C; Robert P
    J Alzheimers Dis; 2014; 38(3):541-9. PubMed ID: 24018266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of drug treatments for Alzheimer's disease in France: a study on a national level based on the National Alzheimer's Data Bank (Banque Nationale Alzheimer).
    Tifratene K; Duff FL; Pradier C; Quetel J; Lafay P; Schück S; Benzenine E; Quantin C; Robert P
    Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):1005-12. PubMed ID: 22718684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Cholinesterase Inhibitors with or without Memantine on Antipsychotic Prescribing.
    Blaszczyk AT; Mang BH; Garza H; Mathys M
    Consult Pharm; 2018 May; 33(5):273-282. PubMed ID: 29789049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined treatment with memantine/es-citalopram for older depressed patients with cognitive impairment: a pilot study.
    Pelton GH; Harper OL; Roose SP; Marder K; D'Antonio K; Devanand DP
    Int J Geriatr Psychiatry; 2016 Jun; 31(6):648-55. PubMed ID: 26559790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of the Antidepressant Prescribing in Alzheimer's Disease and Related Disorders Between 2010 and 2014: Results from the French National Database on Alzheimer's Disease (BNA).
    David R; Manera V; Fabre R; Pradier C; Robert P; Tifratene K
    J Alzheimers Dis; 2016 Jul; 53(4):1365-73. PubMed ID: 27392860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment practices of mild cognitive impairment in California Alzheimer's Disease Centers.
    Weinstein AM; Barton C; Ross L; Kramer JH; Yaffe K
    J Am Geriatr Soc; 2009 Apr; 57(4):686-90. PubMed ID: 19392962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2008-2012 French Alzheimer plan: description of the national Alzheimer information system.
    Le Duff F; Develay AE; Quetel J; Lafay P; Schück S; Pradier C; Robert P;
    J Alzheimers Dis; 2012; 29(4):891-902. PubMed ID: 22366771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological treatment of dementia and mild cognitive impairment due to Alzheimer's disease.
    Popp J; Arlt S
    Curr Opin Psychiatry; 2011 Nov; 24(6):556-61. PubMed ID: 21934621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The French National Alzheimer database: a fast growing database for researchers and clinicians.
    Anthony S; Pradier C; Chevrier R; Festraëts J; Tifratene K; Robert P
    Dement Geriatr Cogn Disord; 2014; 38(5-6):271-80. PubMed ID: 24994018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of mild cognitive impairment that evolves into Alzheimer's disease dementia within two years using a gene expression signature in blood: a pilot study.
    Roed L; Grave G; Lindahl T; Rian E; Horndalsveen PO; Lannfelt L; Nilsson C; Swenson F; Lönneborg A; Sharma P; Sjögren M
    J Alzheimers Dis; 2013; 35(3):611-21. PubMed ID: 23478308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removal of Drugs for Alzheimer's Disease from the List of Reimbursable Drugs in France: Analysis of Change in Drug Use, Disease Management and Cognition Using the National Alzheimer Data Bank (BNA).
    Herr M; Ankri J; Diard C; Hiance-Delahaye A
    Drugs Aging; 2021 Jan; 38(1):63-74. PubMed ID: 33410119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased mean platelet volume and platelet distribution width are associated with mild cognitive impairment and Alzheimer's disease.
    Wang RT; Jin D; Li Y; Liang QC
    J Psychiatr Res; 2013 May; 47(5):644-9. PubMed ID: 23395109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and associated behavioral symptoms of depression in mild cognitive impairment and dementia due to Alzheimer's disease.
    Van der Mussele S; Bekelaar K; Le Bastard N; Vermeiren Y; Saerens J; Somers N; Mariën P; Goeman J; De Deyn PP; Engelborghs S
    Int J Geriatr Psychiatry; 2013 Sep; 28(9):947-58. PubMed ID: 23255479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study.
    Damian M; Hausner L; Jekel K; Richter M; Froelich L; Almkvist O; Boada M; Bullock R; De Deyn PP; Frisoni GB; Hampel H; Jones RW; Kehoe P; Lenoir H; Minthon L; Olde Rikkert MG; Rodriguez G; Scheltens P; Soininen H; Spiru L; Touchon J; Tsolaki M; Vellas B; Verhey FR; Winblad B; Wahlund LO; Wilcock G; Visser PJ
    Dement Geriatr Cogn Disord; 2013; 36(1-2):1-19. PubMed ID: 23651945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
    Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
    Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease.
    Julayanont P; Brousseau M; Chertkow H; Phillips N; Nasreddine ZS
    J Am Geriatr Soc; 2014 Apr; 62(4):679-84. PubMed ID: 24635004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.
    Nolze-Charron G; Mouiha A; Duchesne S; Bocti C;
    J Alzheimers Dis; 2015; 46(4):855-62. PubMed ID: 26402625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease.
    Torres LL; Quaglio NB; de Souza GT; Garcia RT; Dati LM; Moreira WL; Loureiro AP; de Souza-Talarico JN; Smid J; Porto CS; Bottino CM; Nitrini R; Barros SB; Camarini R; Marcourakis T
    J Alzheimers Dis; 2011; 26(1):59-68. PubMed ID: 21593563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.
    van Rossum IA; Visser PJ; Knol DL; van der Flier WM; Teunissen CE; Barkhof F; Blankenstein MA; Scheltens P
    J Alzheimers Dis; 2012; 29(2):319-27. PubMed ID: 22233766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ecological assessment of mild cognitive impairment and Alzheimer disease using the Rivermead Behavioural Memory Test.
    Bolló-Gasol S; Piñol-Ripoll G; Cejudo-Bolivar JC; Llorente-Vizcaino A; Peraita-Adrados H
    Neurologia; 2014; 29(6):339-45. PubMed ID: 24139389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.